Our mission:
end bacterial disease
Our mission:
end bacterial disease
Bacterial infections should never be a death sentence.
Phage therapy has a proven history in addressing bacterial diseases. Before antibiotics, it was a primary tool against infections. Its use declined, not due to lack of effectiveness, but because it could not be produced at scale. The introduction of antibiotics transformed healthcare, but today, antibiotic resistance threatens those gains.
We are facing a global crisis where bacterial infections are becoming increasingly deadly due to antibiotic resistance. The health and economic consequences are staggering, with bacterial disease predicted to be the #1 cause of death by 2050. Alternatives are urgently needed, but nature already has its solution: phages, the natural predators of bacteria.
At Phagos, we are bringing back phage technology by combining advances in microbiology with cutting-edge artificial intelligence. Our patented technology makes large-scale, customized phage-based veterinary medicines possible for the first time. And soon we'll universalize the technology for human health too.
Our mission is to end bacterial disease. This ambitious goal requires a fundamentally different approach built on three core principles that guide our work.
Bacterial infections should never be a death sentence.
Phage therapy has a proven history in addressing bacterial diseases. Before antibiotics, it was a primary tool against infections. Its use declined, not due to lack of effectiveness, but because it could not be produced at scale. The introduction of antibiotics transformed healthcare, but today, antibiotic resistance threatens those gains.
We are facing a global crisis where bacterial infections are becoming increasingly deadly due to antibiotic resistance. The health and economic consequences are staggering, with bacterial disease predicted to be the #1 cause of death by 2050. Alternatives are urgently needed, but nature already has its solution: phages, the natural predators of bacteria.
At Phagos, we are bringing back phage technology by combining advances in microbiology with cutting-edge artificial intelligence. Our patented technology makes large-scale, customized phage-based veterinary medicines possible for the first time. And soon we'll universalize the technology for human health too.
Our mission is to end bacterial disease. This ambitious goal requires a fundamentally different approach built on three core principles that guide our work.
Our Foundation
Our Foundation
01
01
Impact can’t wait
Impact can’t wait
Bacterial disease and the escalating AMR crisis means we need solutions now. To achieve real-world application faster, we’re focusing first on animal health where we can maximize impact on food security, human health, and environmental safety.
Bacterial disease and the escalating AMR crisis means we need solutions now. To achieve real-world application faster, we’re focusing first on animal health where we can maximize impact on food security, human health, and environmental safety.
02
02
Medicine must evolve
Medicine must evolve
As bacteria rapidly adapt to overcome static treatments, the era of one-size-fits-all formulations is ending. The future belongs to personalized precision approaches that continuously redesign treatments to outpace bacterial evolution, ensuring medicines remain effective indefinitely.
As bacteria rapidly adapt to overcome static treatments, the era of one-size-fits-all formulations is ending. The future belongs to personalized precision approaches that continuously redesign treatments to outpace bacterial evolution, ensuring medicines remain effective indefinitely.
03
03
AI is unlocking nature
AI is unlocking nature
The complexity of genomic interactions between phages and bacteria creates infinite potential combinations. Only artificial intelligence can decode these biological relationships fast enough to allow phage therapy to scale.
The complexity of genomic interactions between phages and bacteria creates infinite potential combinations. Only artificial intelligence can decode these biological relationships fast enough to allow phage therapy to scale.
ABOUT US
ABOUT US
Phagos by the numbers
Phagos by the numbers
Phagos is using bacteria’s natural predator, the bacteriophage, to win the fight against antibiotic resistance and cure infectious diseases. We use breakthrough technologies in both the wet lab and dry lab to generate customized treatments for pathogenic diseases at an unprecedented speed.
Phagos is using bacteria’s natural predator, the bacteriophage, to win the fight against antibiotic resistance and cure infectious diseases. We use breakthrough technologies in both the wet lab and dry lab to generate customized treatments for pathogenic diseases at an unprecedented speed.
50
50
50
EMPLOYEES
EMPLOYEES
pulling together expertise across microbiology, AI, and more.
pulling together expertise across microbiology, AI, and more.
19
19
19
NATIONALITIES
NATIONALITIES
creating an environment where everyone feels welcome.
creating an environment where everyone feels welcome.
11
11
11
CLINICAL TRIALS
CLINICAL TRIALS
demonstrating efficacy and safety of our AI-powered phage treatments.
demonstrating efficacy and safety of our AI-powered phage treatments.
€25M
€25M
€25M
FUNDING
FUNDING
to accelerate development and global deployment of our phage solutions.
to accelerate development and global deployment of our phage solutions.
68/32
68/32
68/32
F/M RATIO
F/M RATIO
and proud to be breaking the mold in tech, with women leading the way.
and proud to be breaking the mold in tech, with women leading the way.
300K
300K
300K
ANIMALS TREATED
ANIMALS TREATED
so far on the field, contributing to a healthier food chain, less reliant on antibiotics.
so far on the field, contributing to a healthier food chain, less reliant on antibiotics.
RECRUITMENT
RECRUITMENT
Join us
Join us
We're an inclusive startup where everyone can be 100% themselves. We value good science and good vibes, team lunches, afterworks, and spontaneous coffee breaks are part of the deal.
Apply
Apply
Apply
